首页> 美国卫生研究院文献>Oncology Letters >MicroRNA-30a suppresses the proliferation migration and invasion of human renal cell carcinoma cells by directly targeting ADAM9
【2h】

MicroRNA-30a suppresses the proliferation migration and invasion of human renal cell carcinoma cells by directly targeting ADAM9

机译:MicroRNA-30a通过直接靶向ADAM9抑制人肾细胞癌细胞的增殖迁移和侵袭

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

An increasing number of studies reported that microRNA (miR)-30a was dysregulated in several types of human cancer and may contribute to cancer carcinogenesis and progression. However, its expression and roles in renal cell carcinoma (RCC) remain unknown. In the present study, reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was performed to quantify miR-30a expression in RCC tissues and cell lines. The cell counting kit-8 assay, migration and invasion assays were used to evaluate the roles of miR-30a on the proliferation, migration and invasion of RCC cells. The target gene of miR-30a was identified by luciferase reporter assays, RT-qPCR and western blotting. The results indicated that miR-30a was downregulated in RCC tissues and cell lines compared with corresponding noncancerous tissues and normal renal cell line, respectively. Re-expression of miR-30a inhibited the proliferation, migration and invasion of RCC cells. Additionally, ADAM metallopeptidase domain 9 (ADAM9) was validated as a direct target of miR-30a. Furthermore, the knockdown of ADAM9 by small interfering RNAs was able to mimic the effects of miR-30a overexpression in RCC cells. These results highlight the important role for miR-30a in the occurrence and development of RCC, and the restoration of miR-30a might be investigated as a potential strategy for treating RCC.
机译:越来越多的研究报告说,microRNA(miR)-30a在几种类型的人类癌症中表达失调,可能有助于癌变和发展。然而,其在肾细胞癌(RCC)中的表达和作用仍然未知。在本研究中,进行了逆转录定量聚合酶链反应(RT-qPCR)以量化miR-30a在RCC组织和细胞系中的表达。使用细胞计数试剂盒8检测,迁移和侵袭测定来评估miR-30a在RCC细胞增殖,迁移和侵袭中的作用。 miR-30a的靶基因通过荧光素酶报告基因分析,RT-qPCR和Western blotting鉴定。结果表明,与相应的非癌组织和正常肾细胞系相比,miR-30a在RCC组织和细胞系中分别下调。 miR-30a的重新表达抑制了RCC细胞的增殖,迁移和侵袭。此外,ADAM金属肽酶结构域9(ADAM9)被确认为miR-30a的直接靶标。此外,通过小分子干扰RNA抑制ADAM9能够模拟RCC细胞中miR-30a过表达的作用。这些结果凸显了miR-30a在RCC发生和发展中的重要作用,miR-30a的恢复可能被视为治疗RCC的潜在策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号